Log In
Print
BCIQ
Print
Print this Print this
 

Bosatria, mepolizumab (SB-240563)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionHumanized IgG mAb against IL-5
Molecular Target Interleukin-5 (IL-5)
Mechanism of ActionInterleukin-5 (IL-5) inhibitor; Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today